Company

DIAGNOSTIC BIOCHIPS IS REVOLUTIONIZING THE FUTURE OF IMPLANTABLE NEURAL SENSORS AND REAL TIME CHEMOSENSING.

Our Team

Our team has been working tirelessly in research and development for decades, leading the way in generating new bioelectronics therapies for humans. Our goal is to be the recognized benchmark for multi-parameter in vivo sensing, using demonstrably superior technology for monitoring of the rapidly-changing chemical and biophysical environment of the body. 

DBC TEAM

BRIAN JAMIESON, PHD

President & CEO

Fan Wu, PHD

VP Research and Development

Andrew Hayes

Product Manager

Dongyoul Lee

Senior Engineer

ROB COLLINS, JD

Co-founder and General Counsel

Caitlin Pretz

Senior Engineer

Karen Scida, PHD

Lead Scientist

Scientific Advisory Board

KEVIN PLAXCO, PHD

Professor & Vice Chair, Department of Chemistry and Biochemistry, University of California at Santa Barbara

BARBARA SLUSHER, PHD

Director, Brain Science Institute NeuroTranslation Drug Discovery Program, Johns Hopkins University

X. TRACY CUI, PHD

Associate Professor, Department of Bioengineering, University of Pittsburgh

WARREN GRILL, PHD

Professor, Department of Biomedical Enginering, Duke UniversityŸ

GET IN TOUCH

If you would like to learn more about how Diagnostic Biochips is altering the possibilities of neural and chemical research, please feel free to contact us for more information.

Powered by